The effect of Tamsulosin with or without Tolterodine in treatment of patients with symptomatic BPH in Aria and 22 Bahman hospital in 2012
Subject Areas : علوم پزشکی
Masoud Isapour
1
(استادیار، دانشکده پزشکی، دانشگاه آزاد اسلامی مشهد، مشهد، ایران)
Mahsa Abdollahian Moghadam
2
(دانشجوی پزشکی، دانشکده پزشکی، دانشگاه آزاد اسلامی مشهد، مشهد، ایران)
Keywords: Prostatic hyperplasia, toltrodine, tamsulosin,
Abstract :
Background: Although voiding symptoms are classically related to BPH, as many as 50% of patients can experience irritative symptoms. We compared efficacy of tamsulosin with or without tolterodine in the treatment of patients with symptomatic BPH (benign prostatic hyperplasia). Methods: seventy six patients who fulfilled the inclusion/ exclusion criteria were randomly divided into two groups of tamsulosin monotherapy (0/4 mg/day until 12 weeks) versus tamsulosin (0/4 mg/day until 12 weeks) and Tolterodine (2mg BID for 4 weeks) combination therapy. Therapeutic efficacy was analyzed using international prostate symptom score (IPSS) before and after 4 weeks of treatment. Results: Total IPSS was significantly improved in both groups. Although Combination therapy group showed better improvement in all Lower urinary tract symptoms, but the difference between 2 groups was significant considering complete emptying of bladder, voiding duration less than 2 hours and weak stream (P<0/05). Conclusion: Addition of Tolterodin to Tamsulosin is effective in improving lower urinary tract symptoms in patients with benign prostatic hyperplasia.
_||_